StonvexLoading…
StonvexStonvexStonvexCore line items from KHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-27 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $24.94B | $25.85B | $26.64B | $26.48B |
Operating Income | $-4.67B | $1.68B | $4.57B | $3.63B |
Net Income | $-5.85B | $2.74B | $2.85B | $2.36B |
EPS (Diluted) | $-4.93 | $2.26 | $2.31 | $1.91 |
Total Assets | $81.79B | $88.29B | $90.34B | $90.51B |
Total Liabilities | $40.00B | $38.96B | $40.62B | $41.64B |
Cash & Equivalents | $2.62B | $1.33B | $1.40B | $1.04B |
Free Cash Flow OCF − CapEx | $3.66B | $3.16B | $2.96B | $1.55B |
Shares Outstanding | 1.18B | 1.20B | 1.22B | 1.23B |